reduce insulin dose when starting glp-1 receptor agonist Evolution of GLP‐1 Agonists for Diabetes Treatment GLP-1 Receptor Agonists as Treatments
Description
Peptides 175 , 171179 (2024)
Baekdal TA, Breitschaft A, Navarria A, Hansen CW
Evaluation of exenatide vs
At the end of the original 72-week study, people on the highest dose of either medication were randomized into two arms: the treatment group taking a once-daily dose of orforglipron and a placebo control group
People talk about nausea all the time
